文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

基于生物标志物将急性呼吸衰竭患者分类为炎症亚型:单中心探索性研究

Biomarker-Based Classification of Patients With Acute Respiratory Failure Into Inflammatory Subphenotypes: A Single-Center Exploratory Study.
PubMed 文献 · Crit Care Explor · 2021-08-19
一句话结论在异质性急性呼吸衰竭机械通气人群中可识别高炎症与低炎症亚型,高炎症亚型预后更差,基于4项生物标志物的简化模型可用于预后分层。

本研究为单中心前瞻性观察队列,纳入498例急性呼吸衰竭机械通气患者,基于10项基线血浆生物标志物和临床变量行潜在类别分析,确定两类别模型最优,高炎症亚型占23%。高炎症亚型在ARDS中占31%、ARDS高危中占27%、心衰中占22%,而在气道保护中仅占5%、慢性呼吸衰竭急性加重中占0%。高炎症患者SOFA评分更高、无呼吸机天数更少、30天和90天死亡率更高(均p<0.001)。研究进一步用血管生成素-2、可溶性肿瘤坏死因子受体-1、降钙素原和碳酸氢盐构建简化模型,在139例验证队列中高炎症亚型占19%,其未纳入模型的炎症生物标志物水平更高且预后更差。

要点

  • 在498例急性呼吸衰竭机械通气患者中,潜在类别分析确定两类别模型最优,高炎症亚型占23%。
  • 高炎症亚型分布因病因不同而异:ARDS 31%、ARDS高危27%、心衰22%、气道保护5%、慢性呼吸衰竭急性加重0%。
  • 高炎症亚型患者SOFA评分更高、无呼吸机天数更少、30天和90天死亡率更高(均p<0.001)。
  • 由血管生成素-2、可溶性肿瘤坏死因子受体-1、降钙素原和碳酸氢盐组成的简化模型可在验证队列(n=139)中分类亚型,高炎症占19%。
  • 亚型分类可能更适用于低氧性急性呼吸衰竭病因,而在气道保护或慢性呼吸衰竭急性加重患者中相关性较低。

适用人群与场景

  • 单中心学术医疗ICU中机械通气的急性呼吸衰竭患者,包括ARDS、ARDS高危、充血性心力衰竭、慢性呼吸衰竭急性加重、气道保护和多因素病因。

诊断标准与关键阈值

  • 采用潜在类别分析,考虑临床变量和10项基线血浆生物标志物,确定两类别模型最优,高炎症亚型占23%。
  • 简化预测模型由血管生成素-2、可溶性肿瘤坏死因子受体-1、降钙素原和碳酸氢盐组成,用于分类亚型。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:前瞻性观察队列研究;单中心; derivation队列498例,validation队列139例。
  • 人群:机械通气的急性呼吸衰竭患者,包括ARDS 143例、ARDS高危198例、充血性心力衰竭37例、慢性呼吸衰竭急性加重23例、气道保护61例、多因素35例。
  • 干预与对照:无干预,基于10项基线血浆生物标志物和临床变量行潜在类别分析。
  • 主要终点结果:两类别模型最优,高炎症亚型占23%;高炎症亚型分布:ARDS 31%、ARDS高危27%、心衰22%、慢性呼吸衰竭急性加重0%、气道保护5%、多因素14%。
  • 关键次要终点:高炎症患者SOFA评分更高、无呼吸机天数更少、30天和90天死亡率更高(均p<0.001)。
  • 验证队列:简化模型(血管生成素-2、可溶性肿瘤坏死因子受体-1、降钙素原、碳酸氢盐)分类亚型,高炎症占19%,其未纳入模型的炎症生物标志物水平更高(p<0.01)且预后更差。

证据类型、等级与局限

  • 证据类型:前瞻性、观察性队列研究(单中心探索性研究)。
  • 局限:单中心、探索性研究,样本量有限,需外部验证。

对床旁实践的改变

  • 在急性呼吸衰竭机械通气患者中,基于生物标志物的亚型分类可提供预后分层,高炎症亚型预后更差。
  • 亚型分类可能更适用于低氧性病因(如ARDS、ARDS高危、心衰),而在气道保护或慢性呼吸衰竭急性加重患者中相关性较低。
  • 简化模型(血管生成素-2、可溶性肿瘤坏死因子受体-1、降钙素原、碳酸氢盐)可用于亚型预测,但需前瞻性验证。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Hyper- and hypoinflammatory subphenotypes discovered in patients with acute respiratory distress syndrome predict clinical outcomes and therapeutic responses. These subphenotypes may be important in broader critically ill patient populations with acute respiratory failure regardless of clinical diagnosis. We investigated subphenotyping with latent class analysis in an inclusive population of acute respiratory failure, derived a parsimonious model for subphenotypic predictions based on a small set of variables, and examined associations with clinical outcomes.

DESIGN: Prospective, observational cohort study.

SETTING: Single-center, academic medical ICU.

PATIENTS: Mechanically ventilated patients with acute respiratory failure.

MEASUREMENTS AND MAIN RESULTS: We included 498 patients with acute respiratory failure (acute respiratory distress syndrome: 143, at-risk for acute respiratory distress syndrome: 198, congestive heart failure: 37, acute on chronic respiratory failure: 23, airway protection: 61, and multifactorial: 35) in our derivation cohort and measured 10 baseline plasma biomarkers. Latent class analysis considering clinical variables and biomarkers determined that a two-class model offered optimal fit (23% hyperinflammatory subphenotype). Distribution of hyperinflammatory subphenotype varied among acute respiratory failure etiologies (acute respiratory distress syndrome: 31%, at-risk for acute respiratory distress syndrome: 27%, congestive heart failure: 22%, acute on chronic respiratory failure 0%, airway protection: 5%, and multifactorial: 14%). Hyperinflammatory patients had higher Sequential Organ Failure Assessment scores, fewer ventilator-free days, and higher 30- and 90-day mortality (all p < 0.001). We derived a parsimonious model consisting of angiopoietin-2, soluble tumor necrosis factor receptor-1, procalcitonin, and bicarbonate and classified subphenotypes in a validation cohort (n = 139). Hyperinflammatory patients (19%) demonstrated higher levels of inflammatory biomarkers not included in the model (p < 0.01) and worse outcomes.

CONCLUSIONS: Host-response subphenotypes are observable in a heterogeneous population with acute respiratory failure and predict clinical outcomes. Simple, biomarker-based models can offer prognostic enrichment in patients with acute respiratory failure. The differential distribution of subphenotypes by specific etiologies of acute respiratory failure indicates that subphenotyping may be more relevant in patients with hypoxemic causes of acute respiratory failure and not in patients intubated for airway protection or acute on chronic decompensation.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Drohan CM, Nouraie SM, Bain W, et al. Biomarker-Based Classification of Patients With Acute Respiratory Failure Into Inflammatory Subphenotypes: A Single-Center Exploratory Study. Crit Care Explor. 2021. PMID: 34476405. doi:10.1097/CCE.0000000000000518

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。